Latest News from Origin
Unum – follow-on investment
We are delighted to have lead a follow-on funding round into our Unum, an existing portfolio company producing business class aircraft seating for the new-build (“linefit”) and retrofit markets. Unum has received strong customer interest since our February 2023 investment, and has recently moved to substantial new premises in the Crawley area. This will allow the company to access the local pool of experienced aviation industry professionals and provide the space required to fulfil orders anticipated in 2024 and beyond.
ViaNautis Bio – $25m investment round
Existing Origin portfolio company ViaNautis Bio (formerly SomaServe) has secured $25m in additional finance to further develop and commercialise therapies exploiting its proprietary polyNaut® drug delivery platform. The round was lead by new institutional and corporate venture investors but included significant participation from existing shareholders, including Origin.
Read more here.
Cyclops – expanding into new verticals
Cyclops, the specialist load-sensing business that we first backed in 2019, has raised a significant new funding round. This is to enable the business to expand its operations in two exciting new sectors: Utilities (where its technology can be used in the crucial measurement of power line tension), and Health and well-being, where the company is seeing interest from gym operators and equipment manufacturers, who wish to bring more data and measurement to the exercise experience. Cyclops has already made fantastic inroads into the race and cruising sailing markets.
